It is hence imperative that ALDH1A1 is methodically targeted, particularly for the acute myeloid leukemia patients of the poor prognosis risk group that overexpress ALDH1A1 RNA. The gene discussed is ALDH1A1; the disease is acute myeloid leukemia.